BioMarin

BioMarinBioMarin
BioMarin

BioMarin

A global biotechnology company focused on developing and commercializing therapies for rare genetic diseases.

DR 721997Active3163San Rafael, United States
Rate

About

BioMarin is a global biotechnology company focused on delivering medicines for people living with rare genetic conditions. They pursue bold science to translate genetic discoveries into new medicines, aiming to unleash the full potential of genetic science by pursuing category-defining therapies that have a profound impact on patients. BioMarin serves patients living with rare conditions, with a particular focus on genetically defined conditions.
Frequently asked

What does BioMarin do?

BioMarin is a global biotechnology company focused on delivering medicines for people living with rare genetic conditions. They pursue bold science to translate genetic discoveries into new medicines, aiming to unleash the full potential of genetic science by pursuing category-defining therapies that have a profound impact on patients. BioMarin serves patients living with rare conditions, with a particular focus on genetically defined conditions.

What is BioMarin's revenue?

StartupHub estimates BioMarin's annual revenue at $292.0M (range $167.6M to $928.9M, 68% confidence), based on comparable companies in the sector.

What is BioMarin's valuation?

StartupHub estimates BioMarin's effective valuation at $74.3B (range $34.4B to $111.1B, 57% confidence), based on comparable companies in the sector.

Where is BioMarin headquartered?

BioMarin is headquartered in San Rafael, California, United States.

When was BioMarin founded?

BioMarin was founded in 1997.

What industry does BioMarin operate in?

BioMarin operates in Biotechnology, Rare Diseases, Genetic Disorders, Enzyme Replacement Therapies, Drug Discovery, Pharmaceuticals.

How many employees does BioMarin have?

BioMarin has approximately 3163 people on record.

HEADCOUNT
3163
DOMAIN RATING
72
Comments

No comments yet. Be the first to share your take.